The estimated Net Worth of John F Sheridan is at least $13.5 Milhão dollars as of 15 August 2024. Mr. Sheridan owns over 8,501 units of Tandem Diabetes Care Inc stock worth over $2,245,034 and over the last 11 years he sold TNDM stock worth over $743,379. In addition, he makes $10,560,900 as President, Chief Executive Officer, e Director at Tandem Diabetes Care Inc.
John has made over 61 trades of the Tandem Diabetes Care Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 8,501 units of TNDM stock worth $363,248 on 15 August 2024.
The largest trade he's ever made was exercising 35,000 units of Tandem Diabetes Care Inc stock on 5 August 2015 worth over $38,850. On average, John trades about 4,413 units every 45 days since 2013. As of 15 August 2024 he still owns at least 52,540 units of Tandem Diabetes Care Inc stock.
You can see the complete history of Mr. Sheridan stock trades at the bottom of the page.
John F. Sheridan serves as President, Chief Executive Officer, Director of the Company. Mr. Sheridan has served on our board of directors since June 2019 and as our President and Chief Executive Officer since March 2019. Prior to that, Mr. Sheridan served as our Executive Vice President and Chief Operating Officer since April 2013. Prior to joining us, Mr. Sheridan served as Chief Operating Officer of Rapiscan Systems, Inc., a provider of security equipment and systems, from March 2012 to February 2013. Mr. Sheridan served as Executive Vice President of Research and Development and Operations for Volcano Corporation, a medical technology company, from November 2004 to March 2010. From May 2002 to May 2004, Mr. Sheridan served as Executive Vice President of Operations at CardioNet, Inc., a medical technology company, now operating as BioTelemetry, Inc. (NASDAQ: BEAT). From March 1998 to May 2002, he served as Vice President of Operations at Digirad Corporation, a medical imaging company. Mr. Sheridan holds a B.S. in Chemistry from the University of West Florida and an M.B.A. from Boston University.
As the President, Chief Executive Officer, e Director of Tandem Diabetes Care Inc, the total compensation of John Sheridan at Tandem Diabetes Care Inc is $10,560,900. There are no executives at Tandem Diabetes Care Inc getting paid more.
John Sheridan is 64, he's been the President, Chief Executive Officer, e Director of Tandem Diabetes Care Inc since 2019. There are 3 older and 19 younger executives at Tandem Diabetes Care Inc. The oldest executive at Tandem Diabetes Care Inc is Dick Allen, 75, who is the Lead Independent Director.
John's mailing address filed with the SEC is 12400, High Bluff Drive, San Diego, San Diego County, California, 92130, United States.
Over the last 11 years, insiders at Tandem Diabetes Care Inc have traded over $154,253,951 worth of Tandem Diabetes Care Inc stock and bought 4,118,443 units worth $11,618,906 . The most active insiders traders include Group Holdings (Sbs) Adviso..., Douglas A Roeder, eNicole Vitullo. On average, Tandem Diabetes Care Inc executives and independent directors trade stock every 9 days with the average trade being worth of $885,878. The most recent stock trade was executed by Shannon Marie Hansen on 15 August 2024, trading 1,968 units of TNDM stock currently worth $84,093.
tandem diabetes care, inc. is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. the company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. tandem manufactures and sells the t:slim x2™ insulin pump, the only pump capable of remote feature updates using a personal computer, and the t:flex® insulin pump, the first pump designed for people with greater insulin requirements. tandem is based in san diego, california. safety information please note that this account is not intended to be used for product support or medical advice. if you are having a medical emergency, please dial 911. if you are having an issue with one of our products and need immediate assistance, please call our 24 hour customer support team at 877-801-6901 and press 1 twice. tandem insulin pumps are intended for the subcutan
Tandem Diabetes Care Inc executives and other stock owners filed with the SEC include: